tiprankstipranks
Trending News
More News >

OncoSil Medical Ltd Announces Director’s Interest Change

Story Highlights
OncoSil Medical Ltd Announces Director’s Interest Change

Confident Investing Starts Here:

An announcement from OncoSil Medical Ltd ( (AU:OSL) ) is now available.

OncoSil Medical Ltd has announced a change in the director’s interest, with Lelde Smits acquiring 7,500 options under the company’s Long-Term Incentive (LTI) Scheme. This acquisition reflects the company’s ongoing efforts to align its leadership’s interests with long-term strategic goals, potentially impacting the company’s governance and stakeholder confidence.

More about OncoSil Medical Ltd

OncoSil Medical Ltd is a company operating in the medical industry, focusing on the development and commercialization of innovative medical devices. The company is primarily involved in creating products aimed at improving cancer treatment outcomes, with a focus on delivering targeted radiation therapy solutions.

Average Trading Volume: 35,776

Technical Sentiment Signal: Strong Sell

Current Market Cap: A$13.79M

For detailed information about OSL stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1